Kinetics of immune responses elicited after three mRNA COVID-19 vaccine doses in predominantly antibody-deficient individuals
Erola Ainsua‐Enrich, Núria Pedreño-López, Carmen Bracke, Carlos Ávila‐Nieto, Maria Luisa Rodrı́guez de la Concepción, Edwards Pradenas, Benjamin Trinité, Sílvia Marfil, Cristina Miranda, Sandra González, Ruth Toledo, Marta Font, Susana Benet, Tuixent Escribà, Esther Jiménez‐Moyano, Ruth Peña, Samandhy Cedeño, Júlia G. Prado, Beatriz Mothe, Christian Brander, Nuria Izquierdo‐Useros, Júlia Vergara‐Alert, Joaquím Segalés, Marta Massanella, Rosa Maria Benítez, Alba Romero, Daniel Molina‐Morant, Julià Blanco, Bonaventura Clotet, Lourdes Mateu, María Luisa Pedro-Botet, Jorge Carrillo
Abstract
T cells. CID and TID patients developed cellular but not humoral responses. Although the third vaccine dose boosted humoral responses in most PAD patients, it had limited effect on expanding cellular immunity. Vaccine-induced immune responses in PAD individuals are heterogeneous, and should be immunomonitored to define a personalized therapeutic strategies.